Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Matsumoto

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 9. Discovery and development of new antimicrobial agents]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 21, 2012
[Practical use of urinary antigen test for diagnosis of pathogen causing pneumonia]Tetsuya Matsumoto
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 18, 2013
[The problem and current situation of drug-resistant bacteria in medical settings]Tetsuya Matsumoto
Clinical Pharmacology : Advances and Applications|October 10, 2014
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogensTetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Practical strategies against bioterrorism]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[The cutting-edge of medicine; Microbiological and clinical approach to multidrug resistant bacteria, such as multidrug-resistant Pseudomonas aeruginosa, multidrug-resistant Acinetobacter, NDM-1 producing bacteria]Tetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2003
[Fosfomycin]Tetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 26, 2007
[Bacterial translocation]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. Infectious diseases--recent trend and future issues: 1) Infection with Gram-positive coccus including MRSA]Tetsuya Matsumoto
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2020
In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPETakashi Okanda, Tetsuya Matsumoto
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|August 16, 2016
[111th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: 9. Discovery and development of new antimicrobial agents]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|February 21, 2012
[Practical use of urinary antigen test for diagnosis of pathogen causing pneumonia]Tetsuya Matsumoto
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 18, 2013
[The problem and current situation of drug-resistant bacteria in medical settings]Tetsuya Matsumoto
Clinical Pharmacology : Advances and Applications|October 10, 2014
Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogensTetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Practical strategies against bioterrorism]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 20, 2011
[The cutting-edge of medicine; Microbiological and clinical approach to multidrug resistant bacteria, such as multidrug-resistant Pseudomonas aeruginosa, multidrug-resistant Acinetobacter, NDM-1 producing bacteria]Tetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 2, 2003
[Fosfomycin]Tetsuya Matsumoto
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 26, 2007
[Bacterial translocation]Tetsuya Matsumoto
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|December 5, 2012
[109th Scientific Meeting of the Japanese Society of Internal Medicine: symposium: 3. Infectious diseases--recent trend and future issues: 1) Infection with Gram-positive coccus including MRSA]Tetsuya Matsumoto
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2020
In vitro effect of an antimicrobial combination therapy without colistin and tigecycline for CPE and non-CPETakashi Okanda, Tetsuya Matsumoto
Pageof 27